Stereotactic Ablative Body Radiotherapy for Bone Only Oligometastatic Breast Cancer
“Practice Update” recently highlighted the results of a clinical trial involving stereotactic ablative body radiotherapy (SABR), a noninvasive approach for the treatment... Read More
Clinical Trials for Metastatic Breast Cancer Webinar: April 21, Noon CST
MBCN Teams With Research Advocacy Network to Offer Webinar on Clinical Trials for Metastatic Breast Cancer DATE: Friday April 21, 2017 TIME:... Read More
MBCN Supports Metastatic Breast Cancer Researchers at University of Chicago With Leadership Awards
MBCN supports the triple negative metastatic breast cancer research of Dr. Rita Nanda as well as the oligometastatic breast cancer research of Dr. Steven Chmura. Each received an MBCN Research Leadership Award for $30,000. The awards are made possible from contributions sent to MBCN from individuals, families and work colleagues who want to honor or remember loved ones, colleagues, and friends with metastatic breast cancer.